Curis, Inc. (CRIS) vs Finch Therapeutics Group, Inc. (FNCHQ)

Curis, Inc. and Finch Therapeutics Group, Inc. are both Biotechnology companies. Curis, Inc. is the larger, with a market value of $1.8M against $1.6M — 1.2× the size. Curis, Inc. grew revenue faster over the last twelve months: −13.4% against −96.0%. Across the 12 metrics below, Curis, Inc. leads on 7 and Finch Therapeutics Group, Inc. on 5.

Valuation

Metric CRIS FNCHQ Biotechnology median
P/E n/m n/m 7.88
P/S 0.19 27.07 11.47
P/B 0.38 1.17 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 4.67 47.86 10.73
Earnings yield (1,713.25%) (85.22%) (28.84%)
Free cash flow yield (1,748.82%) (100.64%) (23.03%)

Profitability

Metric CRIS FNCHQ Biotechnology median
Gross margin 99.52% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 455.35% (67.28%) (57.72%)
Return on assets (87.76%) (25.20%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CRIS FNCHQ Biotechnology median
Revenue growth (TTM) (13.43%) (96.00%) 5.64%
EPS growth (last fiscal year) 91.57% 35.36% —
Revenue growth, 5-year CAGR (2.71%) — 8.40%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric CRIS FNCHQ Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.49 3.87 4.73
Net debt to EBITDA 0.91 0.31 0.96

Dividend

Metric CRIS FNCHQ Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric CRIS FNCHQ Biotechnology median
Market cap 1.84m 1.57m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack